TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 12 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,000 | -20.0% | 5,000 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | 0.0% | 5,000 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | 0.0% | 5,000 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | 0.0% | 5,000 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | 0.0% | 5,000 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | 0.0% | 5,000 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | -100.0% | 5,000 | -100.0% | 0.00% | -100.0% |
| Q4 2020 | $28,753,000 | +31.8% | 28,897,000 | +28.5% | 0.01% | +16.7% |
| Q3 2020 | $21,821,000 | +0.8% | 22,484,000 | +0.6% | 0.01% | 0.0% |
| Q2 2020 | $21,649,000 | -2.3% | 22,355,000 | -6.6% | 0.01% | -25.0% |
| Q1 2020 | $22,155,000 | -16.2% | 23,937,000 | -14.2% | 0.01% | +14.3% |
| Q4 2019 | $26,438,000 | -11.2% | 27,891,000 | -15.2% | 0.01% | -12.5% |
| Q3 2019 | $29,761,000 | +9.0% | 32,871,000 | +10.1% | 0.01% | 0.0% |
| Q2 2019 | $27,307,000 | -12.9% | 29,864,000 | -12.2% | 0.01% | -11.1% |
| Q1 2019 | $31,349,000 | +12.3% | 34,005,000 | +9.9% | 0.01% | 0.0% |
| Q4 2018 | $27,913,000 | +35.0% | 30,928,000 | +39.9% | 0.01% | +50.0% |
| Q3 2018 | $20,680,000 | -23.9% | 22,113,000 | -24.5% | 0.01% | -25.0% |
| Q2 2018 | $27,161,000 | +6.9% | 29,303,000 | +1.1% | 0.01% | 0.0% |
| Q1 2018 | $25,411,000 | +40.9% | 28,995,000 | +41.1% | 0.01% | +60.0% |
| Q4 2017 | $18,036,000 | -13.9% | 20,555,000 | -11.5% | 0.01% | -16.7% |
| Q3 2017 | $20,936,000 | +743.9% | 23,228,000 | +904.2% | 0.01% | +500.0% |
| Q2 2017 | $2,481,000 | -28.5% | 2,313,000 | -28.5% | 0.00% | 0.0% |
| Q1 2017 | $3,471,000 | -55.1% | 3,233,000 | -54.2% | 0.00% | -66.7% |
| Q4 2016 | $7,731,000 | -67.9% | 7,060,000 | -65.0% | 0.00% | -66.7% |
| Q3 2016 | $24,055,000 | -11.5% | 20,162,000 | -7.1% | 0.01% | -18.2% |
| Q2 2016 | $27,190,000 | -31.9% | 21,697,000 | -29.3% | 0.01% | -31.2% |
| Q1 2016 | $39,937,000 | +31.3% | 30,690,000 | +57.5% | 0.02% | +33.3% |
| Q4 2015 | $30,415,000 | +34.8% | 19,480,000 | +17.1% | 0.01% | +33.3% |
| Q3 2015 | $22,563,000 | -3.3% | 16,636,000 | -0.3% | 0.01% | 0.0% |
| Q2 2015 | $23,323,000 | +262.9% | 16,689,000 | +284.4% | 0.01% | +800.0% |
| Q1 2015 | $6,426,000 | +108.6% | 4,342,000 | +92.6% | 0.00% | 0.0% |
| Q4 2014 | $3,080,000 | +1.0% | 2,254,000 | -5.1% | 0.00% | 0.0% |
| Q3 2014 | $3,048,000 | -1.0% | 2,375,000 | -1.5% | 0.00% | 0.0% |
| Q2 2014 | $3,080,000 | +0.3% | 2,410,000 | -0.4% | 0.00% | 0.0% |
| Q1 2014 | $3,072,000 | +16.7% | 2,420,000 | -2.4% | 0.00% | 0.0% |
| Q4 2013 | $2,633,000 | +2.5% | 2,480,000 | +0.0% | 0.00% | 0.0% |
| Q3 2013 | $2,570,000 | -25.3% | 2,479,000 | -24.6% | 0.00% | -50.0% |
| Q2 2013 | $3,442,000 | – | 3,286,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Radcliffe Capital Management, L.P. | 70,783,000 | $69,363,000 | 6.27% |
| INCOME RESEARCH & MANAGEMENT | 14,978,000 | $14,536,000 | 5.17% |
| PIPER SANDLER & CO. | 5,000,000 | $4,852,000 | 3.63% |
| Western Asset Management Company, LLC | 42,946,000 | $42,102,000 | 3.46% |
| PenderFund Capital Management Ltd. | 4,000,000 | $5,225,000 | 1.45% |
| Bracebridge Capital, LLC | 5,500,000 | $5,335,000 | 0.85% |
| WESTWOOD HOLDINGS GROUP INC | 43,185,000 | $42,490,000 | 0.54% |
| CORBYN INVESTMENT MANAGEMENT INC/MD | 1,025,000 | $995,000 | 0.52% |
| LMR Partners LLP | 22,235,000 | $21,742,000 | 0.45% |
| JUPITER ASSET MANAGEMENT LTD | 35,000,000 | $34,357,000 | 0.36% |